Dr Preethi Eldi

Senior Research Fellow

School of Pharmacy and Biomedical Sciences

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.


Year Citation
2026 Khetan, R., Rajapaksha, W., Nturubika, B. D., Gillam, T. A., Brooks, D. A., Garg, S., . . . Eldi, P. (2026). Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells. Frontiers in Drug Delivery, 5, 15 pages.
DOI
2025 Stacey, D., Gaziano, L., Eldi, P., Toben, C., Benyamin, B., Lee, S. H., & Hyppönen, E. (2025). A Transcriptome-Wide Mendelian Randomization Study in Isolated Human Immune Cells Highlights Risk Genes Involved in Viral Infections and Potential Drug Repurposing Opportunities for Schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 198(6), 19-31.
DOI Scopus5 WoS5 Europe PMC2
2025 Khetan, R., Lokman, N. A., Eldi, P., Price, Z. K., Oehler, M. K., Brooks, D. A., . . . Albrecht, H. (2025). Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. International Journal of Molecular Sciences, 26(17), 8529.
DOI Scopus3 WoS3 Europe PMC3
2024 Khetan, R., Eldi, P., Lokman, N. A., Ricciardelli, C., Oehler, M. K., Blencowe, A., . . . Albrecht, H. (2024). Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation.. J Ovarian Res, 17(1), 156.
DOI Scopus3 WoS3 Europe PMC3
2022 Eldi, P., Cooper, T. H., Prow, N. A., Liu, L., Heinemann, G. K., Zhang, V. J., . . . Hayball, J. D. (2022). The vaccinia-based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses. Immunology and Cell Biology, 100(4), 250-266.
DOI Scopus4 WoS3 Europe PMC2
2021 Yu, M., Teo, T., Yang, Y., Li, M., Long, Y., Philip, S., . . . Wang, S. (2021). Potent and orally bioavailable CDK8 inhibitors: design, synthesis, structure-activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry, 214, 1-22.
DOI Scopus16 WoS14 Europe PMC15
2020 Le, T. T. A., Fok, J. S., Vareeckal Joseph, S., Eldi, P., Chataway, T., Smith, W., & Hissaria, P. (2020). Transplant induced food sensitization without allergy-mechanisms of tolerance. Journal of Allergy and Clinical Immunology, 8(5), 1757-1760.
DOI Scopus3 WoS2 Europe PMC3
2020 Day, J., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., . . . Hayball, J. D. (2020). Aberrant expression of high mobility group box protein 1 in the idiopathic inflammatory myopathies. Frontiers in Cell and Developmental Biology, 8(article no. 226 q 1), 11 pages.
DOI Scopus13 WoS14 Europe PMC14
2020 Prow, N. A., Liu, L., McCarthy, M. K., Walters, K., Kalkeri, R., Geiger, J., . . . Suhrbier, A. (2020). The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. NPJ Vaccines, 5(1, article no. 44), 44-1-44-10.
DOI Scopus21 WoS16 Europe PMC17
2019 Moldenhauer, L. M., Schjenken, J. E., Hope, C. M., Green, E. S., Zhang, B., Eldi, P., . . . Robertson, S. A. (2019). Thymus-derived regulatory T cells exhibit Foxp3 epigenetic modification and phenotype attenuation after mating in mice. Journal of Immunology, 203(3), 647-657.
DOI Scopus35 WoS34 Europe PMC33
2019 Guzman-Genuino, R. M., Eldi, P., Garcia-Valtanen, P., Hayball, J. D., & Diener, K. R. (2019). Uterine B cells exhibit regulatory properties during the peri-implantation stage of murine pregnancy. Frontiers in Immunology, 10(2899), 2899-1-2899-12.
DOI Scopus22 WoS19 Europe PMC16
2019 Eldi, P., Cooper, T., Ward, M., & Hayball, J. D. (2019). How emerging vaccine technologies are pushing disease prevention boundaries. International pharmacy journal, 37(1), 16-19.
2019 Eldi, P., Chaudhri, G., Nutt, S. L., Newsome, T. P., & Karupiah, G. (2019). Viral replicative capacity, antigen availability via hematogenous spread, and high T FH:T FR ratios drive induction of potent neutralizing antibody responses. Journal of virology, 93(6, article no. e01795-18), 17 pages.
DOI Scopus6 WoS6 Europe PMC5
2018 Duncan, M. L., Horsington, J., Eldi, P., Al Rumaih, Z., Karupiah, G., & Newsome, T. P. (2018). Loss of actin-based motility impairs ectromelia virus release in vitro but is not critical to spread in vivo. Viruses, 10(3), E111.
DOI Scopus6 Europe PMC5
2018 Zhang, W., Song, Y., Eldi, P., Guo, X., Hayball, J., Garg, S., & Albrecht, H. (2018). Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles. International Journal of Nanomedicine, 13, 293-305.
DOI Scopus50 WoS38 Europe PMC27
2018 Prow, N., Liu, L., Nakayama, E., Cooper, T., Yan, K., Eldi, P., . . . Suhrbier, A. (2018). A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Nature Communications, 9(1), 1230-1-1230-12.
DOI Scopus74 WoS69 Europe PMC68
2017 Liu, L., Cooper, T., Eldi, P., Garcia-Valtanen, P., Diener, K., Howley, P., & Hayball, J. (2017). Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from Vaccinia virus. BioTechniques, 62(4), 183-187.
DOI Scopus4 WoS4 Europe PMC4
2017 Eldi, P., Cooper, T., Liu, L., Prow, N., Diener, K., Howley, P., . . . Hayball, J. (2017). Production of a chikungunya vaccine using a CHO cell and attenuated viral-based platform technology. Molecular Therapy, 25(10), 2332-2344.
DOI Scopus19 WoS19 Europe PMC19
2017 Wijesundara, D., Yu, W., Quah, B., Eldi, P., Hayball, J., Diener, K., . . . Grubor-Bauk, B. (2017). Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner. Scientific Reports, 7(1), 8530-1-8530-8.
DOI Scopus8 WoS9 Europe PMC9
2016 Zhang, W., Garg, S., Eldi, P., Zhou, F., Johnson, I., Brooks, D., . . . Albrecht, H. (2016). Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide. International Journal of Pharmaceutics, 513(1-2), 270-279.
DOI Scopus28 WoS26 Europe PMC18
2016 Tao, B., Bernardo, K., Eldi, P., Chegeni, N., Wiese, M., Colella, A., . . . Chataway, T. (2016). Extended boiling of peanut progressively reduces IgE allergenicity while retaining T cell reactivity. Clinical and Experimental Allergy, 46(7), 1004-1014.
DOI Scopus48 WoS43 Europe PMC29
2015 Sakala, I. G., Chaudhri, G., Scalzo, A. A., Eldi, P., Newsome, T. P., Buller, R. M., & Karupiah, G. (2015). Evidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve Mice. Plos Pathogens, 11(12), 26 pages.
DOI Scopus11 WoS10 Europe PMC9
2015 Chaudhri, G., Tahiliani, V., Eldi, P., & Karupiah, G. (2015). Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses. Journal of Virology, 89(3), 1889-1899.
DOI Scopus15 Europe PMC13
2015 Sakala, I. G., Chaudhri, G., Eldi, P., Buller, R. M., & Karupiah, G. (2015). Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection. PLoS one, 10(3, article no. e0118685), 1-21.
DOI Scopus7 Europe PMC6
2014 Andoniou, C. E., Sutton, V. R., Wikstrom, M. E., Fleming, P., Thia, K. Y. T., Matthews, A. Y., . . . Degli Esposti, M. A. (2014). A natural genetic variant of granzyme B confers lethality to a common viral infection. PLoS pathogens, 10(12, article no. e1004526), 1-13.
DOI Scopus16 Europe PMC14
2013 Tahiliani, V., Chaudhri, G., Eldi, P., & Karupiah, G. (2013). The orchestrated functions of innate leukocytes and T cell subsets contribute to humoral immunity, virus control, and recovery from secondary poxvirus challenge. Journal of Virology, 87(7), 3852-3861.
DOI Scopus10 Europe PMC10
2009 Lee, S. H., Eldi, P., Cho, S. Y., & Rangasamy, D. (2009). Control of chicken CR1 retrotransposons is independent of Dicer-mediated RNA interference pathway. BMC Biology, 7(article no. 53), 1-14.
DOI Scopus15 Europe PMC12
2009 Eldi, P., & Rietze, R. L. (2009). Flow cytometric characterization of neural precursor cells and their progeny. Methods in Molecular Biology, 549, 77-89.
DOI Scopus3 Europe PMC2

Year Citation
2021 Prow, N., Howley, P., Cooper, T., Hayball, J., Diener, K. R., Liu, L., & Eldi, P. (2021). US20210299245A1, Attenuated poxvirus vector based vaccine for protection against covid-19.
  • Sementis SCV Vaccine Development Laboratory Reagents and Consumables, Sementis Pty Ltd, 01/01/2026 - 30/06/2026

  • Sementis SCV Vaccine Development Research Fellow Support, Sementis Pty Ltd, 31/12/2025 - 30/06/2026

  • Bridge and Bridgetech Industry Fellowship - Fellowship from MTPConnect, MTP Connect-MRFF REDI Fellowships, 24/10/2023 - 08/11/2023

Courses I teach

  • PHAR 2010 Drug Discovery (2025)
  • PHAR 3013 Drug Development 2 (2025)
  • PHAR 2009 Drug Development 1 (2024)
  • PHAR 2010 Drug Discovery (2024)
  • PHAR 3013 Drug Development 2 (2024)
  • PHAR 3025 Dosage Form Design 4 (2024)

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor 111081 - Introducing a new paradigm for specific targeting of ovarian cancer cells with engineered nanoparticles, using G protein-coupled receptors as molecular entry points Doctor of Philosophy Doctorate Full Time Mr Weranga Rajapaksha Gedara
2023 Principal Supervisor Assessment of almond -specific antibody levels in participants from the Almond Weight Loss Study Master of Research (Health) Master Part Time Mrs Belinda Clark
2022 Principal Supervisor Preclinical evaluation of passive and active immunotherapies for melanoma Doctor of Philosophy Doctorate Full Time Ms Samantha Jane Watson

Connect With Me

External Profiles

Other Links